1.
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiologica...
by Yusuf, Salim, Prof
The Lancet (British edition), 2011, Vol.378 (9798), p.1231-1243
2.
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
by Rothwell, Peter M, Prof
The Lancet (British edition), 2010, Vol.375 (9718), p.895-905
3.
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
by Chapman, Neil
Hypertension (Dallas, Tex. 1979), 2007-04, Vol.49 (4), p.839-845
4.
Prevalence of Resistant Hypertension in the United States, 2003–2008
by Persell, Stephen D
Hypertension (Dallas, Tex. 1979), 2011-06, Vol.57 (6), p.1076-1080
5.
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
by Esser, Nathalie
Diabetologia, 2019-05-14, Vol.62 (7), p.1113-1122
6.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
7.
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
by Gerdts, Eva
Hypertension (Dallas, Tex. 1979), 2007-02, Vol.49 (2), p.311-316
8.
Description of Antihypertensive Use in Patients With Resistant Hypertension Prescribed Four or More Agents
by Hanselin, Michele R
Hypertension (Dallas, Tex. 1979), 2011-12, Vol.58 (6), p.1008-1013
9.
Atenolol in hypertension: is it a wise choice?
by Carlberg, Bo
The Lancet (British edition), 2004, Vol.364 (9446), p.1684-1689
10.
Effect of Baseline Cognitive Function and Antihypertensive Treatment on Cognitive and Cardiovascular Outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)
by Skoog, Ingmar
American journal of hypertension, 2005, Vol.18 (8), p.1052-1059
11.
Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients
by Okin, Peter M
Hypertension (Dallas, Tex. 1979), 2004-07, Vol.44 (1), p.48-54
12.
Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study
by Kizer, Jorge R
Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.46-52
13.
QRS Duration and QT Interval Predict Mortality in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention for Endpoint Reduction in Hypertension Study
by Oikarinen, Lasse
Hypertension (Dallas, Tex. 1979), 2004-05, Vol.43 (5), p.1029-1034
14.
Serum Uric Acid Is Associated With New-Onset Diabetes in Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Study
by Wiik, Benedicte P.
American journal of hypertension, 2010-08, Vol.23 (8), p.845-851
15.
Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER
by Mogensen, Carl Erik
Hypertension (Dallas, Tex. 1979), 2003-05, Vol.41 (5), p.1063-1071
16.
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patien...
by Okin, Peter M
Hypertension (Dallas, Tex. 1979), 2007-11, Vol.50 (5), p.984-990
17.
Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients
by Okin, Peter M.
American journal of hypertension, 2010-07, Vol.23 (7), p.786-793
18.
Relations of Serum Aldosterone to Cardiac Structure: Gender-Related Differences in the Framingham Heart Study
by Vasan, Ramachandran S
Hypertension (Dallas, Tex. 1979), 2004-05, Vol.43 (5), p.957-962
19.
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme
by Hawkins, N M
Heart (British Cardiac Society), 2007-01, Vol.93 (1), p.59-64
20.
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proo...
by Townsend, Raymond R
The Lancet (British edition), 2017-11-11, Vol.390 (10108), p.2160-2170
